Catalog
Hypothalamic & Pituitary Signaling · Evidence Level II

Kisspeptin

Reproductive neuropeptide

Kisspeptin peptides are endogenous regulators of reproductive neuroendocrine signaling and are studied in puberty, fertility, hypothalamic function, and gonadotropin release.

For laboratory and research use only. Not for human or veterinary use.

Form

Lyophilized

Available strengths

10 mg

Research class

Hypothalamic & Pituitary Signaling

Evidence grade

Level II

Meaningful but investigational human research

01

Scientific overview

Kisspeptin peptides are endogenous regulators of reproductive neuroendocrine signaling and are studied in puberty, fertility, hypothalamic function, and gonadotropin release.

02

Mechanism under investigation

Activates KISS1R on hypothalamic GnRH neurons, which can stimulate downstream LH and FSH secretion.

03

Research evidence summary

Meaningful human experimental evidence; still investigational for most proposed uses.

Level II, Meaningful human investigation

04

Key research limitations

Different kisspeptin isoforms and analogues are not interchangeable. Responses vary by sex, reproductive state, and protocol.

05

Safety & toxicology context

Potential effects include reproductive-hormone changes, headache, flushing, and unknown long-term endocrine consequences.

06

Regulatory & development status

Investigational for most applications; no broadly marketed FDA-approved kisspeptin drug.

Supplied strictly for in-vitro and ex-vivo laboratory research. Not for human or veterinary administration, diagnostic, or therapeutic use. Import and regulatory compliance remain the responsibility of the receiving researcher.

07

Lot documentation

Every Cendrix lot ships with an HPLC purity chromatogram, mass-spectrometry identity confirmation, appearance and reconstitution observations, and endotoxin testing where applicable. Lot certificates are retrievable from the Quality page using the lot number printed on the vial.

08

Curated references

External searches link to PubMed, ClinicalTrials.gov, Google Scholar, and FDA records. Cendrix does not endorse interpretations published in third-party sources.

Editorial provenance

Last scientific review
June 2026
Literature search through
June 2026
Regulatory review status
Pending counsel approval

Persistent disclaimer

For laboratory research use only. Not for human or veterinary use, diagnosis, treatment, prevention, or personal experimentation. This content summarizes published research and is not medical advice.